The Behavioral Neuroscience of Drug Discrimination

  • Joseph H. Porter
  • Adam J. Prus

Part of the Current Topics in Behavioral Neurosciences book series (CTBN, volume 39)

Table of contents

  1. Front Matter
    Pages i-x
  2. Joseph H. Porter, Adam J. Prus, Donald A. Overton
    Pages 3-26
  3. Michael D. Berquist, William E. Fantegrossi
    Pages 29-49
  4. Daicia C. Allen, Matthew M. Ford, Kathleen A. Grant
    Pages 95-111
  5. Joseph H. Porter, Kevin A. Webster, Adam J. Prus
    Pages 193-212
  6. S. Stevens Negus, Matthew L. Banks
    Pages 245-259
  7. B. Levi Bolin, Joseph L. Alcorn, Anna R. Reynolds, Joshua A. Lile, William W. Stoops, Craig R. Rush
    Pages 261-295
  8. Anthony L. Riley, Matthew M. Clasen, Mary A. Friar
    Pages 297-317

About this book


The goal for this volume is to provide an up-to-date review of the discriminative stimulus properties of major psychoactive drug classes with an emphasis on how this paradigm enhances our understanding of these drugs and how these findings translate from animals to humans. The drug discrimination paradigm applies to both drugs of abuse and drugs for treating mental illnesses, and research from these studies has provided immense translational value for learning about the mechanisms responsible for drug effects in humans.


Discriminative Stimulus Properties of Drugs Drug Abuse Drug Discovery Drug Discrimination Pharmacotherapeutic Drugs Translational Research

Editors and affiliations

  • Joseph H. Porter
    • 1
  • Adam J. Prus
    • 2
  1. 1.Department of PsychologyVirginia Commonwealth UniversityRichmondUSA
  2. 2.Department of Psychological ScienceNorthern Michigan UniversityMarquetteUSA

Bibliographic information

Industry Sectors
Health & Hospitals